Ligand Pharmaceuticals
LGND
#4123
Rank
โ‚น187.73 B
Marketcap
โ‚น9,935
Share price
-6.81%
Change (1 day)
57.21%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): โ‚น128.21

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น136.93. In 2022 the company made an earnings per share (EPS) of -โ‚น172.69 a decrease over its 2021 EPS that were of โ‚น301.77.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น128.21-174.24%
2022-โ‚น172.69-157.23%
2021โ‚น301.77-2571.43%
2020-โ‚น12.21-100.46%
2019โ‚น2,670353.48%
2018โ‚น588.711025%
2017โ‚น52.33-700%
2016-โ‚น8.72-100.87%
2015โ‚น1,0081859.32%
2014โ‚น51.465.36%
2013โ‚น48.848.0704505322479E+18%
2012โ‚น0.0000000000-100%
2011โ‚น42.74-194.23%
2010-โ‚น45.35548.38%
2009-โ‚น6.99-98.7%
2008-โ‚น539.00-136.52%
2007โ‚น1,476-787.8%
2006-โ‚น214.55-14.58%
2005-โ‚น251.18-21.31%
2004-โ‚น319.21-55.15%
2003-โ‚น711.6981.33%
2002-โ‚น392.482.74%
2001-โ‚น382.01-45.93%
2000-โ‚น706.46-14.56%
1999-โ‚น826.82-45.52%
1998-โ‚น1,518-3.97%
1997-โ‚น1,580132.31%
1996-โ‚น680.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น1,234 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น31.40-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น305.32 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น158.88 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น162.22 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น473.53 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น346.25 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น446.55 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,228 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA